Current regulatory challenges and approaches in the registration of herbal drugs in Europe

References

• Guidelines for the appropriate use of herbal medicines. Who regional publications, western pacific series no. 23. Manilla: World Health Organization, Regional Office for the Western Pacific; 1998.
   Google Scholar
• General guidelines for methodologies on research and evaluation of traditional medicine. Who/edm/trm/2000.1., Geneva: World Health Organization; 2000.
   Google Scholar
• Traditional medicine. Fact sheet no. 134. World Health Organization, Geneva. 2008. Available online at: http://www.Who.Int/mediacentre/factsheets/fs134/en/, accessed 27 Apr 2011.
   Google Scholar
• Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in us- and Indian-manufactured Ayurvedic medicines sold via the internet. J Amer Med Asso 2008;300:915–23.
   PubMed Web of Science ®Google Scholar
• Peter AG M, De Smet. Herbal remedies. New Engl J Med 2002;347:2046–56.
   PubMed Web of Science ®Google Scholar
• USFDA. Draft guidance for industry on botanical drug products. U. S. Department of Health and Human Services, Food and Drug Administration and Center of Drug Evaluation and Research; 2000. p 1–22.
   Google Scholar
• EMEA. Guidance on herbal products. London: The European Agency for the Evaluation of Medicinal Products; 2001. p 1–10.
   Google Scholar
• WHO Quality Control Guidelines for Medicinal plant materials. Geneva: World Health Organization; 1998. p 1–111.
   Google Scholar
• Wallis TE. Textbook of pharmacognosy. New Delhi: CBS publication; 2002. p 78–571.
   Google Scholar
• Patwardhan B. A method of treating musculoskeletal disease and a novel composition thereof. US Pat 5, 1996: 494, 668.
   Google Scholar
• Evans WC. Trease and Evans pharmacognosy. London: W. B. Saunders, Elsevier; 2002. p 102.
   Google Scholar
• Laxmikumaran MS, Singh A, Negi MS, et al. Assessment of genetic diversity of medicinal plants: case study on Withania somnifera. Presented in Int Workshop on Biotechnol Interven for Dry land Agriculture: Opportunities and Constraints; 2002.
   Google Scholar
• Joshi K, Chavan P, Warude D, et al. Molecular markers in herbal drug technology. Curr Sci 2004;87:159–65.
   Web of Science ®Google Scholar
• Nrayana DBA, Baba B, Katiyar CK. Herbal remedies: Through GMP/HACCCP techniques. Eastern Pharmacist 1997;9:21–7.
   Google Scholar
• Vijaya KD, Raghavan KV. Novel Chromatographic fingerprinting method for standardization of single medicines and formulations, WO 0246739-EP2 0000991 991- 263397CSIR G01N30-88. Hyderabad: Indian Institute of Chemical Technology; 2002.
   Google Scholar
• Frazier RA. Capillary electrophoresis for food analysis- Method development. UK: The Royal Society of Chemistry; 2000. p 1–20.
   Google Scholar
• An exploration of current issues in botanical quality: a discussion paper. Canada: Natural Health Products Directorate; 2002. p 1–32.
   Google Scholar
• Wolf HT, Zundorf I, Winckler T, et al. Characterization of Echinacea and detection of possible adulterants by RAPD analysis. Planta Med 1999;65:773–4.
   PubMed Web of Science ®Google Scholar
• Cheng KT, Tsay HS, Chen CF, et al. Determination of components in a Chinese preparation “Yu- Ping-Feng San” by RAPD analysis. Planta Med 1998;64:563–5.
   PubMed Web of Science ®Google Scholar
• Shaw PC, But PP. Adulteration of Panax species and their adulterants by random-primed polymerase reaction. Planta Med 1995;61:649–2.
   Web of Science ®Google Scholar
• Lalita SK. DNA markers in plant improvement: aAn overview. Biotech Adv 1999;17:143–82.
   PubMed Web of Science ®Google Scholar
• Raina MK. Quality control of herbal and herbo-mineral formulations. Ind J Nat Prods 2003;19:11–15.
   Google Scholar
• Ernst E, Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther 2001;70:497–504.
   PubMed Web of Science ®Google Scholar
• Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002;252:107–13.
   PubMed Web of Science ®Google Scholar
• Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 2002;23:136–9.
   PubMed Web of Science ®Google Scholar
• De Smet P AGM. Adverse effects of herbal drugs: toxicological outlook on the quality assurance of herbal medicines. Berlin: Springer Verlag; 1992. p 1–72.
   Google Scholar
• Quality of herbal remedies. The rules governing medicinal products in the European Community. Luxembourg: Office for Official Publications of the European Communities; 1989. p 31.
   Google Scholar
• Chan TYK, Chan JCN, Tomlinson B, et al. Chinese herbal medicine revisited: a Hong Kong perspective. Lancet 1993;342:1532–4.
   PubMed Web of Science ®Google Scholar
• Brown S, Ede R. Occult lead poisoning. Br J Hosp Med 1995;53:469.
   PubMed Web of Science ®Google Scholar
• Schaumburg HH, Berger A. Alopecia and sensory polyneuropathy from thallium in a Chinese herbal medication. JAMA 1992;268:3430–1.
   PubMed Web of Science ®Google Scholar
• Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1995;121:729–35.
   Web of Science ®Google Scholar
• Vanherweghem JL, Depierreux M, Tielemans C. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387–91.
   PubMed Web of Science ®Google Scholar
• Chan TYK, Critchley JAJH. Usage and adverse effects of Chinese herbal medicines. Hum Exp Toxicol 1996;15:5–12.
   PubMed Web of Science ®Google Scholar
• Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001;16:115–17.
   PubMed Web of Science ®Google Scholar
• Atherton DJ, Rustin MH, Brostoff J. Need for correct identification of herbs in herbal poisoning. Lancet 1993;341:637–8.
   PubMed Web of Science ®Google Scholar
• EMEA. Position paper on the risks associated with the use of herbal products containing Aristolochia species. EMEA/HMPWP/23/00; 2000.
   Google Scholar
• Ernst E. Herb-drug interactions: potentially important but woefully under-researched. Eur J Clin Pharmacol 2000;56:523–4.
   PubMed Web of Science ®Google Scholar
• ICDRA. International Conference on Drug Regulatory Authorities. World Health Organization; 1986.
   Google Scholar
• ICDRA. 6th International Conference on Drug Regulatory Authorities. World Health Organization; 1991.
   Google Scholar
• ICDRA. 8th International Conference on Drug Regulatory Authorities. Bahrain: World Health Organization; 1996.
   Google Scholar
• ICDRA. 9th International Conference on Drug Regulatory Authorities. Berlin: World Health Organization; 1999.
   Google Scholar
• Shia G, Noller B, Burford G. Safety issues and policies. In: Bodeker G, editors. Traditional, complementary and alternative medicine: policy and public health perspectives. London: Imperial College Press; 2007. p 83–98.
   Google Scholar
• Wu KM, Ghantous H, Birnkrant DB. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. Food Chem Toxicol 2008;46:2606–10.
   PubMed Web of Science ®Google Scholar
• Wu KM, Dou J, Ghantous H, et al. Current regulatory perspectives on genotoxicity testing for botanical drug product development in the USA. Regul Toxicol Pharmacol 2010;56:1–3.
   PubMed Web of Science ®Google Scholar
• Evans S. Changing the knowledge base in western herbal medicine. Soc Sci Med 2008;67:2098–106.
   PubMed Web of Science ®Google Scholar
• Directive 2004/24/EC of The European Parliament and of The Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Available online at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000264.jsp&mid=WC0b01ac0580028e7c, accessed 30 Apr 2004.
   Google Scholar
• European Agency for the Evaluation of Medicinal Products Report from the Adhoc Working Group on Herbal Medicinal Products 1997/1998 EMEA/HMPWG/25/99.
   Google Scholar
• Directive 2004/24/EC of the European Parliament and of the Council. Available online at: http://Eurlex.europa.eu/LexUriServ/LexUriServ.do?Uri=OJ:L:2004:136:0085:0090, accessed 20 Mar 2012.
   Google Scholar
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use [homepage on the Internet]. Available online at: http://www.edctp.org/fileadmin/documents/ethics/DIRECTIVE_200183EC_OF_THE_EUROPEAN_PARLIAMENT, accessed 20 Mar 2012.
   Google Scholar